Nolvadex (Tamoxifen Citrate) 20 mg – 30 Tablet

Biochem Nolvadex (Tamoxifen Citrate) 20 mg – 30 Tablets | Oral Selective Estrogen Receptor Modulator

Biochem Nolvadex (Tamoxifen Citrate) 20 mg – 30 Tablets is an oral pharmaceutical product. This product contains tamoxifen citrate, a nonsteroidal selective estrogen receptor modulator (SERM) that interacts with estrogen receptors and modifies estrogen-dependent biological signaling.

Tamoxifen citrate is widely associated with the pharmaceutical brand name Nolvadex. It has established medical applications in the treatment and risk reduction of certain hormone receptor-positive breast cancers.

Tamoxifen belongs to the triphenylethylene family of compounds and exhibits tissue-dependent estrogen receptor antagonist and agonist activities.

Its primary pharmacological mechanism involves binding to estrogen receptors and altering the transcriptional activity of estrogen-responsive genes.

In breast tissue, tamoxifen generally acts as an estrogen receptor antagonist, reducing estrogen-mediated stimulation of susceptible breast cancer cells.

However, tamoxifen can exhibit partial estrogen agonist activity in other tissues, including bone and the endometrium.

Unlike aromatase inhibitors such as anastrozole (Arimidex) and exemestane (Aromasin), tamoxifen does not primarily inhibit estrogen biosynthesis. Instead, it modifies estrogen receptor signaling.

Tamoxifen citrate is metabolized into several biologically active compounds, including endoxifen and 4-hydroxytamoxifen, which contribute substantially to its estrogen receptor-modulating effects.

The cytochrome P450 enzyme CYP2D6 plays an important role in endoxifen formation. Certain medications that inhibit CYP2D6 may reduce endoxifen exposure.

Tamoxifen has also been studied in selected male endocrine and reproductive conditions, including gynecomastia and certain infertility-related disorders.

However, established indications differ by jurisdiction, and use for hormonal changes associated with anabolic-androgenic steroid exposure is not an established indication.

Tamoxifen is not an anabolic-androgenic steroid, testosterone preparation, aromatase inhibitor, or peptide hormone.

Nolvadex is a pharmaceutical brand name associated with tamoxifen. Use of this name in a Biochem product description does not independently establish equivalence to a particular authorized branded preparation.

Biochem Nolvadex 20 mg contains 20 mg of tamoxifen citrate per tablet, with 30 tablets per package, as specified for this product. This represents 600 mg of total stated tamoxifen citrate content per package.

An important formulation distinction is that some pharmaceutical tamoxifen products express tablet strength as tamoxifen base equivalent rather than the mass of tamoxifen citrate. The exact strength convention should be confirmed against the manufacturer's specifications before making equivalence claims.

1. Modulates Estrogen Receptor Signaling

Tamoxifen interacts with estrogen receptors and changes their response to endogenous estrogen.

In breast tissue, tamoxifen generally produces antiestrogenic effects by interfering with estrogen-dependent gene transcription.

Its actions are tissue-specific, meaning its effects in bone, the endometrium, and other organs can differ from those observed in breast tissue.

2. Reduces Estrogen-Dependent Signaling in Breast Tissue

Tamoxifen can reduce estrogen-mediated stimulation of hormone receptor-positive breast cancer cells.

This mechanism underlies its established use in selected breast cancer treatment settings.

Clinical effectiveness depends on tumor characteristics, receptor status, treatment circumstances, and other medical factors.

3. Has Established Applications in Hormone Receptor-Positive Breast Cancer

Tamoxifen has an extensive history of clinical use in selected estrogen receptor-positive breast cancer treatment settings.

It may be used in appropriate patients as part of adjuvant endocrine therapy or in other established treatment circumstances.

It also has recognized risk-reduction applications in certain high-risk populations, depending on jurisdiction and clinical eligibility.

4. Produces Tissue-Dependent Estrogen Agonist and Antagonist Effects

Tamoxifen is classified as a selective estrogen receptor modulator because its effects differ among tissues.

It generally antagonizes estrogen signaling in breast tissue but can exhibit partial estrogen agonist activity in the endometrium and bone.

These tissue-specific properties contribute to both its clinical applications and its adverse-effect profile.

5. Undergoes Conversion into Active Metabolites

Tamoxifen undergoes hepatic metabolism to form several metabolites.

Endoxifen and 4-hydroxytamoxifen have important estrogen receptor-modulating activity.

CYP2D6 contributes to endoxifen formation, making certain drug interactions clinically relevant.

6. Has Been Studied in Male Endocrine Conditions

Tamoxifen has been studied in selected male endocrine conditions, including gynecomastia and some reproductive disorders.

By modifying estrogen receptor signaling, it may influence hormonal feedback and gonadotropin secretion in certain physiological circumstances.

However, tamoxifen is not equivalent to testosterone replacement therapy, and its use for post-anabolic-steroid hormonal recovery is not an established indication.

7. Has Important Thromboembolic, Endometrial, and Visual Safety Considerations

Tamoxifen can increase the risk of venous thromboembolism, including deep vein thrombosis and pulmonary embolism.

It can also increase the risk of endometrial abnormalities, including endometrial cancer, particularly in patients with a uterus.

Other potential adverse effects include hot flashes, nausea, menstrual changes, cataracts, visual disturbances, and liver-related abnormalities.

Tamoxifen requires appropriate medical supervision because its tissue-dependent estrogen receptor effects can produce serious adverse outcomes. Warning signs such as unusual vaginal bleeding, new visual disturbances, chest pain, shortness of breath, or painful leg swelling warrant prompt medical evaluation. Tamoxifen may cause fetal harm and should not be used during pregnancy.

The 20 mg tablet strength and 30-tablet package quantity describe the requested product presentation. Neither establishes an appropriate dosage, frequency, treatment duration, or individual medical indication.

Step 1 – Oral Administration and Gastrointestinal Absorption

Tamoxifen is administered orally in established pharmaceutical formulations.

Following administration, it is absorbed through the gastrointestinal tract and enters systemic circulation.

Its absorption and systemic exposure can vary with formulation and individual physiological factors.

Step 2 – Distribution and Estrogen Receptor Interaction

Tamoxifen distributes throughout the body and reaches tissues containing estrogen receptors.

It interacts with estrogen receptor-mediated signaling pathways.

The biological response depends on tissue type, receptor characteristics, and associated regulatory proteins.

Step 3 – Modulation of Estrogen-Dependent Gene Transcription

Tamoxifen modifies estrogen receptor activity and the transcription of estrogen-responsive genes.

In breast tissue, this generally reduces estrogen-dependent stimulation.

In other tissues, partial estrogen agonist activity may occur.

Step 4 – Formation of Active Metabolites

Hepatic metabolism produces active metabolites, including endoxifen and 4-hydroxytamoxifen.

These metabolites contribute substantially to the overall pharmacological effects of tamoxifen.

Drug interactions affecting CYP2D6 may influence endoxifen exposure.

Step 5 – Metabolism and Elimination

Tamoxifen undergoes extensive hepatic metabolism.

The elimination half-life of tamoxifen is approximately five to seven days, while certain metabolites may persist longer.

Elimination occurs predominantly through fecal pathways following metabolic transformation.

Tamoxifen has been manufactured in oral solid-dose pharmaceutical formulations, including 20 mg presentations.

The Biochem Nolvadex 20 mg oral tablet presentation is described by the following characteristics:

• Tamoxifen citrate as the stated active ingredient.
• A stated tablet strength of 20 mg.
• A package quantity of 30 tablets.
• A total stated active ingredient content of 600 mg.
• Oral solid-dose pharmaceutical presentation.
• Nonsteroidal selective estrogen receptor modulator classification.
• Triphenylethylene-derived chemical structure.
• Tissue-dependent estrogen receptor agonist and antagonist effects.
• Antiestrogenic activity in breast tissue.
• Modulation of estrogen-dependent gene transcription.
• Established applications in selected breast cancer settings.
• Recognized risk-reduction applications in eligible populations.
• Formation of active metabolites including endoxifen.
• Important CYP2D6-related drug interaction considerations.
• No primary aromatase inhibition.
• No direct anabolic-androgenic steroid activity.
• Extensive hepatic metabolism.
• Relatively prolonged elimination characteristics.
• Important thromboembolic and endometrial safety considerations.
• Potential visual and hepatic adverse effects.
• Product identity, purity, and content uniformity requiring analytical verification.

The precise excipient composition, tablet appearance, strength-expression convention, and manufacturing specifications of Biochem Nolvadex 20 mg have not been independently confirmed.

The product should not be represented as authentic branded Nolvadex or as an approved interchangeable generic without independent verification.

United States

Biochem Nolvadex 20mg, Biochem Tamoxifen Citrate 20mg, Nolvadex 20mg 30 tablets, Tamoxifen 20mg tablets, Nolvadex United States, Tamoxifen citrate oral tablets, Nolvadex selective estrogen receptor modulator, Tamoxifen mechanism of action, Nolvadex estrogen receptor activity, Tamoxifen breast cancer pharmacology, Nolvadex endoxifen metabolite, Tamoxifen CYP2D6 metabolism, Nolvadex molecular formula, Tamoxifen chemical structure, Nolvadex breast cancer treatment, Tamoxifen safety information, Nolvadex tablet specifications.

Canada

English: Biochem Nolvadex 20mg Canada, Tamoxifen Citrate 20mg Canada, Nolvadex 30 tablets Canada, Tamoxifen oral tablets, Nolvadex selective estrogen receptor modulator, Tamoxifen properties, Nolvadex pharmacology, Tamoxifen estrogen receptor activity, Nolvadex endoxifen, Tamoxifen CYP2D6 metabolism, Nolvadex mechanism of action, Tamoxifen breast cancer treatment, Nolvadex safety information.

French: Biochem Nolvadex 20 mg Canada, citrate de tamoxifène 20 mg, Nolvadex 30 comprimés, modulateur sélectif des récepteurs des œstrogènes, propriétés du tamoxifène, pharmacologie du Nolvadex, récepteurs des œstrogènes, métabolite endoxifène, métabolisme CYP2D6, traitement du cancer du sein hormonodépendant, mécanisme d'action du tamoxifène, composition des comprimés, informations de sécurité.

United Kingdom

Biochem Nolvadex 20mg UK, Tamoxifen Citrate 20mg UK, Nolvadex 30 tablets, Tamoxifen oral tablets, Nolvadex selective oestrogen receptor modulator, Tamoxifen pharmacology, Nolvadex oestrogen receptor activity, Tamoxifen endoxifen metabolite, Nolvadex CYP2D6 metabolism, Tamoxifen molecular composition, Nolvadex mechanism of action, Tamoxifen breast cancer treatment, Nolvadex tablet formulation.

Germany

Biochem Nolvadex 20 mg Deutschland, Tamoxifen 20 mg, Tamoxifencitrat, Nolvadex 30 Tabletten, selektiver Östrogenrezeptormodulator, Tamoxifen Eigenschaften, Nolvadex Wirkungsmechanismus, Tamoxifen Zusammensetzung, Östrogenrezeptor, Endoxifen Metabolit, CYP2D6 Stoffwechsel, hormonrezeptorpositiver Brustkrebs, Tamoxifen Molekülstruktur, Leberstoffwechsel, Nolvadex Sicherheitsinformationen.

France

Biochem Nolvadex 20 mg France, citrate de tamoxifène 20 mg, Nolvadex 30 comprimés, modulateur sélectif des récepteurs des œstrogènes, propriétés du tamoxifène, mécanisme d'action du Nolvadex, composition du tamoxifène, récepteur des œstrogènes, métabolite endoxifène, métabolisme CYP2D6, cancer du sein hormonodépendant, structure moléculaire, métabolisme hépatique, informations de sécurité.

Spain

Biochem Nolvadex 20 mg España, citrato de tamoxifeno 20 mg, Nolvadex 30 tabletas, modulador selectivo de los receptores de estrógeno, propiedades del tamoxifeno, cómo funciona el Nolvadex, composición del tamoxifeno, receptor de estrógenos, metabolito endoxifeno, metabolismo CYP2D6, cáncer de mama hormonodependiente, estructura molecular, metabolismo hepático, mecanismo de acción del Nolvadex, información de seguridad.

Italy

Biochem Nolvadex 20 mg Italia, tamoxifene citrato 20 mg, Nolvadex 30 compresse, modulatore selettivo del recettore degli estrogeni, proprietà del tamoxifene, meccanismo d'azione del Nolvadex, composizione del tamoxifene, recettore degli estrogeni, metabolita endoxifene, metabolismo CYP2D6, carcinoma mammario ormonosensibile, struttura molecolare, metabolismo epatico, informazioni di sicurezza.

Portugal

Biochem Nolvadex 20 mg Portugal, citrato de tamoxifeno 20 mg, Nolvadex 30 comprimidos, modulador seletivo dos recetores de estrogénio, propriedades do tamoxifeno, mecanismo de ação do Nolvadex, composição do tamoxifeno, recetores de estrogénio, metabolito endoxifeno, metabolismo CYP2D6, cancro da mama hormonossensível, estrutura molecular, metabolismo hepático, informações de segurança.

Netherlands

Biochem Nolvadex 20 mg Nederland, tamoxifencitraat 20 mg, Nolvadex 30 tabletten, selectieve oestrogeenreceptormodulator, eigenschappen van tamoxifen, werkingsmechanisme Nolvadex, samenstelling van tamoxifen, oestrogeenreceptor, endoxifen metaboliet, CYP2D6 metabolisme, hormoongevoelige borstkanker, moleculaire structuur, levermetabolisme, veiligheidsinformatie.

Belgium

Biochem Nolvadex 20 mg Belgium, Nolvadex 20 mg België, tamoxifencitraat 20 mg, citrate de tamoxifène 20 mg, Nolvadex 30 tabletten, Nolvadex 30 comprimés, selectieve oestrogeenreceptormodulator, modulateur sélectif des récepteurs des œstrogènes, eigenschappen van tamoxifen, propriétés du tamoxifène, oestrogeenreceptor, récepteur des œstrogènes, endoxifen metaboliet, métabolite endoxifène, CYP2D6 metabolisme, veiligheidsinformatie.

Switzerland

Biochem Nolvadex 20 mg Switzerland, Nolvadex 20 mg Schweiz, Nolvadex 20 mg Suisse, Tamoxifen 20 mg, citrate de tamoxifène 20 mg, Nolvadex 30 Tabletten, Nolvadex 30 comprimés, selektiver Östrogenrezeptormodulator, modulateur sélectif des récepteurs des œstrogènes, Tamoxifen Eigenschaften, propriétés du tamoxifène, Östrogenrezeptor, récepteur des œstrogènes, Endoxifen Metabolit, métabolite endoxifène, Hormonregulation.

Austria

Biochem Nolvadex 20 mg Österreich, Tamoxifen 20 mg, Nolvadex 30 Tabletten, Tamoxifencitrat, selektiver Östrogenrezeptormodulator, Tamoxifen Eigenschaften, Nolvadex Wirkungsmechanismus, Östrogenrezeptor, Endoxifen Metabolit, CYP2D6 Stoffwechsel, hormonrezeptorpositiver Brustkrebs, Molekülstruktur, Leberstoffwechsel, Tamoxifen Zusammensetzung, Sicherheitsinformationen.

Sweden

Biochem Nolvadex 20 mg Sverige, tamoxifencitrat 20 mg, Nolvadex 30 tabletter, selektiv östrogenreceptormodulator, tamoxifen egenskaper, Nolvadex verkningsmekanism, östrogenreceptor, endoxifen metabolit, CYP2D6 metabolism, hormonreceptorpositiv bröstcancer, molekylstruktur, levermetabolism, Nolvadex farmakologi, säkerhetsinformation.

Norway

Biochem Nolvadex 20 mg Norge, tamoksifensitrat 20 mg, Nolvadex 30 tabletter, selektiv østrogenreseptormodulator, tamoksifen egenskaper, Nolvadex virkningsmekanisme, østrogenreseptor, endoksifen metabolitt, CYP2D6 metabolisme, hormonreseptorpositiv brystkreft, molekylstruktur, levermetabolisme, Nolvadex farmakologi, sikkerhetsinformasjon.

Denmark

Biochem Nolvadex 20 mg Danmark, tamoxifencitrat 20 mg, Nolvadex 30 tabletter, selektiv østrogenreceptormodulator, tamoxifen egenskaber, Nolvadex virkningsmekanisme, østrogenreceptor, endoxifen metabolit, CYP2D6 metabolisme, hormonreceptorpositiv brystkræft, molekylstruktur, levermetabolisme, Nolvadex farmakologi, sikkerhedsinformation.

Finland

Biochem Nolvadex 20 mg Suomi, tamoksifeenisitraatti 20 mg, Nolvadex 30 tablettia, selektiivinen estrogeenireseptorin muuntelija, tamoksifeenin ominaisuudet, Nolvadex vaikutusmekanismi, estrogeenireseptori, endoksifeeni metaboliitti, CYP2D6 aineenvaihdunta, hormonireseptoripositiivinen rintasyöpä, molekyylirakenne, maksametabolia, Nolvadex farmakologia, turvallisuustiedot.

Poland

Biochem Nolvadex 20 mg Polska, cytrynian tamoksyfenu 20 mg, Nolvadex 30 tabletek, selektywny modulator receptora estrogenowego, właściwości tamoksyfenu, mechanizm działania Nolvadex, skład tamoksyfenu, receptor estrogenowy, metabolit endoksyfen, metabolizm CYP2D6, hormonozależny rak piersi, struktura molekularna, metabolizm wątrobowy, informacje o bezpieczeństwie.

Czech Republic

Biochem Nolvadex 20 mg Česko, tamoxifen-citrát 20 mg, Nolvadex 30 tablet, selektivní modulátor estrogenových receptorů, vlastnosti tamoxifenu, mechanismus účinku Nolvadex, složení tamoxifenu, estrogenový receptor, metabolit endoxifen, metabolismus CYP2D6, hormonálně pozitivní karcinom prsu, molekulární struktura, jaterní metabolismus, bezpečnostní informace.

Romania

Biochem Nolvadex 20 mg România, citrat de tamoxifen 20 mg, Nolvadex 30 comprimate, modulator selectiv al receptorilor estrogenici, proprietăți tamoxifen, mecanism de acțiune Nolvadex, compoziția tamoxifenului, receptor estrogenic, metabolit endoxifen, metabolism CYP2D6, cancer mamar hormonodependent, structură moleculară, metabolism hepatic, informații de siguranță.

Greece

Biochem Nolvadex 20 mg Ελλάδα, κιτρική ταμοξιφαίνη 20 mg, Nolvadex 30 δισκία, εκλεκτικός τροποποιητής υποδοχέων οιστρογόνων, ιδιότητες ταμοξιφαίνης, μηχανισμός δράσης Nolvadex, σύνθεση ταμοξιφαίνης, υποδοχέας οιστρογόνων, μεταβολίτης ενδοξιφαίνη, μεταβολισμός CYP2D6, ορμονοευαίσθητος καρκίνος μαστού, μοριακή δομή, ηπατικός μεταβολισμός, πληροφορίες ασφάλειας.

Ireland

Biochem Nolvadex 20mg Ireland, Tamoxifen Citrate 20mg Ireland, Nolvadex 30 tablets, Tamoxifen oral tablets, Nolvadex selective oestrogen receptor modulator, Tamoxifen pharmacology, Nolvadex oestrogen receptor activity, Tamoxifen endoxifen metabolite, Nolvadex CYP2D6 metabolism, Tamoxifen molecular composition, Nolvadex mechanism of action, Tamoxifen breast cancer treatment, Nolvadex tablet formulation.

Colombia

Biochem Nolvadex 20 mg Colombia, citrato de tamoxifeno 20 mg Colombia, Nolvadex 30 tabletas, modulador selectivo de los receptores de estrógeno, propiedades del tamoxifeno, cómo funciona el Nolvadex, farmacología del tamoxifeno, composición del Nolvadex, receptor de estrógenos, metabolito endoxifeno, metabolismo CYP2D6, cáncer de mama hormonodependiente, estructura molecular, metabolismo hepático, mecanismo de acción del Nolvadex, información de seguridad.

Argentina

Biochem Nolvadex 20 mg Argentina, citrato de tamoxifeno 20 mg Argentina, Nolvadex 30 comprimidos, modulador selectivo de los receptores de estrógeno, propiedades del tamoxifeno, qué es el Nolvadex, cómo actúa el tamoxifeno, farmacología del Nolvadex, receptor de estrógenos, metabolito endoxifeno, metabolismo CYP2D6, cáncer de mama hormonodependiente, estructura molecular, metabolismo hepático, composición del Nolvadex.

México

Biochem Nolvadex 20 mg México, citrato de tamoxifeno 20 mg México, Nolvadex 30 tabletas, modulador selectivo de los receptores de estrógeno, propiedades del tamoxifeno, para qué se utiliza el Nolvadex, cómo funciona el tamoxifeno, farmacología del Nolvadex, receptor de estrógenos, metabolito endoxifeno, metabolismo CYP2D6, cáncer de mama con receptores hormonales positivos, estructura molecular, mecanismo de acción del Nolvadex, información de seguridad.

Perú

Biochem Nolvadex 20 mg Perú, citrato de tamoxifeno 20 mg Perú, Nolvadex 30 tabletas, modulador selectivo de los receptores de estrógeno, propiedades del tamoxifeno, qué es el tamoxifeno, cómo funciona el Nolvadex, farmacología del Nolvadex, receptor de estrógenos, metabolito endoxifeno, metabolismo CYP2D6, cáncer de mama hormonodependiente, estructura molecular, metabolismo hepático, composición del Nolvadex.

Venezuela

Biochem Nolvadex 20 mg Venezuela, citrato de tamoxifeno 20 mg Venezuela, Nolvadex 30 tabletas, modulador selectivo de los receptores de estrógeno, propiedades del tamoxifeno, qué es el Nolvadex, cómo actúa el tamoxifeno, farmacología del Nolvadex, receptor de estrógenos, metabolito endoxifeno, metabolismo CYP2D6, cáncer de mama hormonodependiente, estructura molecular, metabolismo hepático, composición del Nolvadex.

Ecuador

Biochem Nolvadex 20 mg Ecuador, citrato de tamoxifeno 20 mg Ecuador, Nolvadex 30 tabletas, modulador selectivo de los receptores de estrógeno, propiedades del tamoxifeno, para qué se utiliza el Nolvadex, cómo funciona el tamoxifeno, farmacología del Nolvadex, receptor de estrógenos, metabolito endoxifeno, metabolismo CYP2D6, cáncer de mama hormonodependiente, estructura molecular, metabolismo hepático, composición del Nolvadex, mecanismo de acción del tamoxifeno, información de seguridad.

Biochem Nolvadex (Tamoxifen Citrate) 20mg | 30 Tablets | Selective Estrogen Receptor Modulator

Learn about Biochem Nolvadex 20mg, 30 tablets. This product contains tamoxifen citrate, a selective estrogen receptor modulator associated with estrogen receptor signaling, endoxifen metabolism, and established applications in selected breast cancer treatment settings.

Biochem Nolvadex (Citrato de Tamoxifeno) 20mg | 30 Tabletas | Modulador Selectivo de los Receptores de Estrógeno

Conoce Biochem Nolvadex 20mg, 30 tabletas. Este producto contiene citrato de tamoxifeno, un modulador selectivo de los receptores de estrógeno relacionado con la señalización estrogénica y el tratamiento de determinados tipos de cáncer de mama.

biochem-nolvadex-tamoxifen-citrate-20mg-30-tablets

biochem-nolvadex-citrato-de-tamoxifeno-20mg-30-tabletas

Biochem Nolvadex Tamoxifen Citrate 20mg, 30 oral tablets, a selective estrogen receptor modulator associated with estrogen receptor activity, endoxifen formation, and breast cancer endocrine pharmacology.

Biochem Nolvadex Citrato de Tamoxifeno 20mg, 30 tabletas orales, un modulador selectivo de los receptores de estrógeno relacionado con la actividad estrogénica, la formación de endoxifeno y la farmacología endocrina del cáncer de mama.